TrialAIDS (London, England)2016

Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.

Hans-Jürgen Stellbrink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.